0001104659-19-047282.txt : 20190826
0001104659-19-047282.hdr.sgml : 20190826
20190826161534
ACCESSION NUMBER: 0001104659-19-047282
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190715
FILED AS OF DATE: 20190826
DATE AS OF CHANGE: 20190826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wedell-Wedellsborg Johan
CENTRAL INDEX KEY: 0001753185
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 191053086
MAIL ADDRESS:
STREET 1: RUNGSTED STRANDVEJ 113
CITY: RUNGSTED KYST
STATE: G7
ZIP: 2960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4/A
1
a4a.xml
4/A
X0306
4/A
2019-07-15
2019-07-17
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001753185
Wedell-Wedellsborg Johan
C/O WECO GROUP A/S
RUNGSTED STRANDVEJ 113
RUNGSTED KYST
G7
2960
DENMARK
1
0
1
0
Common Stock
2019-07-15
4
J
0
860105
D
823392
I
By Weco Group A/S
Common Stock
5010000
I
By WG Biotech ApS
Weco Group A/S transferred (a) 540,105 shares of the Common Stock of Y-mAbs Therapeutics, Inc. (the "Company") to shareholders of WG Biotech ApS in exchange for 10,781 ordinary shares of WG Biotech ApS; and (b) 320,000 shares of the Company's Common Stock to shareholders of Weco Biotech ApS in exchange for 20,000 shares of Weco Biotech ApS. The closing sale price of the Company's Common Stock on July 15, 2019, the date of the transaction, was $22.95.
Reporting Person is the majority owner of Weco Group A/S and as such has sole voting and dispositive power with respect to such shares.
Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.
/s/ Johan Wedell-Wedellsborg
2019-08-26